Pandect Bioventures
Overview
Pandect Bioventures provides seed to Series A and later funding to early-stage biotech and pharma companies, along with full management support to help entrepreneurs achieve critical business milestones . Pandect Bioventures identifies transformational healthcare ideas at the earliest stage, then leverages the knowledge and resources of our rich ecosystem to help build these ideas into successful life science companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Iris Medicine | May 2020 | Seed | Co-investor |
| Azkarra Therapeutics | Jun 2020 | Seed | Lead |
| Valitor | Oct 2022 | Series B | Co-investor |
| Walden Biosciences | Oct 2020 | Series A | - |
| Circle Pharma | Jun 2021 | Series C | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Pandect Bioventures based?
Pandect Bioventures is headquartered in South San Francisco, California, United States.
When was Pandect Bioventures founded?
Pandect Bioventures was founded in 2018.
How many portfolio companies does Pandect Bioventures have?
Pandect Bioventures has 5 portfolio companies in Caplight's dataset.
What are some companies in Pandect Bioventures's portfolio?
Portfolio companies visible on Caplight include Iris Medicine, Azkarra Therapeutics, Valitor, Walden Biosciences, Circle Pharma.
What was Pandect Bioventures's most recent investment shown here?
Pandect Bioventures's most recent investment in this portfolio sample was in Valitor in 2022.
What sectors does Pandect Bioventures focus on?
Pandect Bioventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Pandect Bioventures focus on?
Pandect Bioventures typically invests at the Mid stage.
What is Pandect Bioventures's AUM?
Pandect Bioventures's assets under management are estimated between $0.0 and $50.0M.